Search   Advanced Search Help | Site Index | Contact Us All |  A |  B |  C |  D |  E |  F |  G |  H |  I |  J |  K |  L |  M |  N |  O |  P |  Q |  R |  S |  T |  U |  V |  W |  X |  Y |  Z Title Last Updated A "State-of-the-Art" Conference on Hepatitis C May 6, 2008 A Case Study Approach to the Clinician's Challenge in Preserving Long-term Renal Function, Implication of Preserving Long-term Renal Function After Renal Transplantation, NIAID, NIH, DHHS Oct. 25, 2007 A Deadly Synergy April 1, 2005 A Delicate Balance: Levels of HIV Replication are Strongly Influenced by Interaction of Positive and Negative Host Factors July 9, 1996 A Framework for Progress on Hepatitis C May 6, 2008 A Helpful Guide to HIV and Metabolic Complications, NIAID, NIH, DHHS Oct. 28, 2008 A Killer Returns: The Face of the Epidemic April 1, 2005 A Leading Cause of Blindness May Be Controlled by Simple Course of Oral Antibiotic Aug. 19, 1999 A Microbe Hunter On Call to the World, Discovery News, NIAID, NIH May 9, 2008 A Multiple-reach Model Describing the Migratory Behavior of Snake River Yearling Chinook Salmon (Oncorhynchus tshawytscha), Can. J. Fish. Aquat. Sci. 55, 1998 Aug. 6, 2007 A New Gold Standard: Improved Animal Model Could Speed Drugs for Chagas’ Disease April 24, 2009 A New Registry for Primary Immune Deficiency Diseases Oct. 30, 1997 A Parasite, a Virus, and a Bacterium: NIAID's Plan to Tackle the World's Leading Killers, NIAID May 7, 2001 A Phase IIB randomized, controlled trial to evaluate the safety, tolerance, and HIV vertical transmission rates associated with short course nevirapine (NVP) vs. short course zidovudine (ZDV) in HIV infected pregnant women and their infants in Uganda July 15, 1999 A Potential New Target for Treating Asthma Dec. 1, 2006 A Safety Evaluation of MDCK for Influenza Vaccine Production, Vaccine Cell Substrate 2004, Practical Experience April 11, 2008 A Small Genetic Change Makes Flu Virus Deadly Sept. 6, 2001 A Timely Test: Real Time PCR March 24, 2009 A view from Washington through the eyes of an AAP physician-scientist, Anthony Fauci, Journal of Clinical Investigation, October 2007 Dec. 26, 2007 Abnormal Immune Cells May Cause Unprovoked Anaphylaxis Nov. 13, 2007 About CFAR, NIAID, NIH April 8, 2009 About CMB, Comparative Medicine Branch July 6, 2006 About NIAID June 14, 2005 About the DAIDS Clinical Research Policies and Standard Procedures Documents, NIAID, NIH March 30, 2009 About the DMID Office of Clinical Research Affairs (OCRA), NIAID, NIH April 19, 2007 About the Research Technologies Branch, NIAID, NIH Sept. 30, 2008 About the TB Bug, Tuberculosis, NIAID, NIH April 1, 2005 About, NIAID HIV and Emerging Infectious Diseases Program, NIAID, NIH Oct. 17, 2006 Abstract: “Enteric Vaccines for Pediatric Use” Workshop Report, April 24-26, 2004, NIAID, NIH Aug. 6, 2007 Abstract: “Hit” to Clinical Candidate: Discovery and Characterization of the Aminomethylcyclines Jan. 6, 2009 Abstract: Antiviral Drug Development for Biothreat Agents, Tove C. Bolken, Head of Research Operations, SIGA Technologies, Inc. Jan. 6, 2009 Abstract: Bacillus anthracis Antimicrobials Derived from Inhibitors of Mammalian Serine-Threonine Kinases, Jimmy D. Ballard, Ph.D. Jan. 6, 2009 Abstract: Challenges of Antibiotic Drug Development in the 21st Century, Karen Bush, Ph. D., Jan. 6, 2009 Abstract: Chop-lump Tests for Vaccine Trials, September 4, 2007 Sept. 20, 2007 Abstract: Combining Focused Antisense Screening Technology (FAST) and Structure-based Drug Design (SBDD) for Antibacterial Discovery Jan. 6, 2009 Abstract: Development of Antiviral RNA Interference Therapeutics, Antonin de Fougerolles Jan. 6, 2009 Abstract: Development of Cysteine Cathepsin Inhibitors as Anti-Ebola Virus Agents - James M. Cunningham Jan. 6, 2009 Abstract: Discovery of Smallpox Inhibitors that Block Processive DNA Synthesis Jan. 6, 2009 Abstract: Dose and Schedule Choices to Suppress Emergence of Resistance G.L. Drusano, M.D., Ordway Research Institute Jan. 6, 2009 Abstract: Efflux Pump Inhibitors: from Tools to Drugs Jan. 6, 2009 Abstract: Identification of Inhibitors of Ebola Virus Using a Subgenomic Replication System Jan. 6, 2009 Abstract: Identification of Small Molecule Inhibitors of Anthrax Lethal Factor Jan. 6, 2009 Abstract: Impact of Drug-Like Properties on Hit Selection and Optimization for Quality Clinical Candidates Jan. 6, 2009 Abstract: Leveraging Structure-Based Drug Design Technologies to Accelerate Drug Candidate Generation Jan. 6, 2009 Abstract: Multi-target Anthrax Antitoxin Therapies, February 7, 2007 Jan. 6, 2009 Abstract: Nucleotides as Anti-HBV Agents, R. P. Iyer, Ph.D. Jan. 6, 2009 Abstract: Old Target, New Approach: Developing Pterin-like Small Molecules as Inhibitors of the Bacterial Folate Pathway Jan. 6, 2009 Abstract: Optimizing the Oral Bioavailability and Activity of Antiviral Drugs, Karl Y. Hostetler Jan. 6, 2009 Abstract: Pitfalls of Target Validation for Novel Antibacterial Strategies, David J. Payne Jan. 6, 2009 Abstract: The Discovery of Orally Active Inhibitors of Respiratory Syncytial Virus, Nicholas A. Meanwell Jan. 6, 2009 Abstract: Use of a Cocktail to Reduce the Need for Drug Interaction Studies During Drug Development - Joseph S. Bertino Jr., Pharm.D., FCP Jan. 6, 2009 Acellular Pertussis Vaccine Proves Effective in Adults, Adolescents Oct. 12, 2005 Acknowledging CFAR, NIAID, NIH Feb. 12, 2009 Acquired Immunodeficiency Review Committee, About NIAID, NIAID, NIH July 22, 2004 Acquired Immunodeficiency Syndrome (AIDS), Selected Scientific Areas of Research Dec. 23, 2004 Acronyms, Comparative Medicine Branch July 2, 2006 ACTG 175, CPCRA 007 Trial Results Published Oct. 9, 1996 ACTG 175: Anti-HIV Therapy Lowers Risk of AIDS Sept. 14, 1995 ACTG 315 Preliminary Results: Drug Cocktail Restores Partial Immune Function Jan. 26, 1997 Actividades del Día de Concientización Sobre la Vacuna Contra el VIH/SIDA, 18 de mayo del 2005 July 30, 2007 Actividades del Día de Concientización Sobre las Vacunas Contra el VIH 18 de Mayo del 2006 July 30, 2007 Adaptively Changing Subgroup Proportions in Clinical Trials, Dean Follman, Statistica Sinica 1997 July 25, 2007 Add Your Voice, Division of AIDS (DAIDS), NIAID, NIH Oct. 1, 2008 Add Your Voice: Opportunties for Community Participation in HIV/AIDS Research, DAIDS, NIAID, NIH July 30, 2007 Adding IL-2 to Potent Anti-HIV Drugs Increases CD4+ T-Cell Counts Without Raising HIV Levels July 8, 2000 Additional Questions and Answers to RFP NIH-NIAID-DMID-PR2004-01 ‘Neutralizing Monoclonal Antibodies Type A for Botulinum Neurotoxins’ Oct. 1, 2008 Additional Questions and Answers to the RFP No. NIH-NIAID-DMID-PR2004-02, ‘Recombinant Type E Botulinum Neurotoxin Vaccine’ Oct. 1, 2008 Additional Resources, HIV/AIDS Specimen Repository April 27, 2009 Additional Resources, New Investigator Workshot, DAIT, NIAID, NIH Nov. 7, 2007 Addressing Antimicrobial Resistance, Slide 7, Testimony of Dr. Fauci, February 25, 1999 Feb. 24, 1999 Addressing Health Disparities: NIAID Agenda, Slide 9, Dr. Anthony S. Fauci, March 1, 2000 March 1, 2000 Adenovirus Potency Assays: Novel Approaches to Current Challenges April 11, 2008 Adjournment, National Advisory Allergy and Infectious Diseases Council January 2005 Minutes March 15, 2005 Adjournment, National Advisory Allergy and Infectious Diseases Council September 1997 Minutes March 13, 2001 Adjournment, National Advisory Allergy and Infectious Diseases Council: February 2000 Minutes March 2, 2001 Adjournment, National Advisory Allergy and Infectious Diseases Council: September 1998 Minutes March 12, 2001 Adjuvants and Other Vaccine Ingredients March 9, 2009 Adriana Marques, M.D., Clinical Studies Unit, Laboratory of Clinical Infectious Diseases, NIAID, NIH June 13, 2008 Adult Male Circumcision Reduces Risk of HIV Acquisition for at Least 3.5 Years Aug. 11, 2008 Adult Male Circumcision Significantly Reduces Risk of Acquiring HIV: Trials in Kenya and Uganda Stopped Early Dec. 13, 2006 Adult Male Circumcision Significantly Reduces Risk of Acquiring HIV: Trials in Kenya and Uganda Stopped Early Dec. 13, 2006 Advanced Product Development for Multiplex Infectious Disease Diagnostics: Summary of a NIAID Workshop Aug. 6, 2007 Advances in AIDS Pathogenesis and Preclinical Vaccine Development April 29, 1997 Adventitious Virus Tests, Vaccine Cell Substrates 2004, June 30, 2004 April 11, 2008 Advice on Preparation of a CFAR Application, NIAID, NIH April 27, 2009 Advisory and Working Groups, HIV/AIDS Vaccines Jan. 14, 2009 Aedes Aegypti Announcement Jan. 5, 2006 Aedes Aegypti Announcement Jan. 5, 2006 Aedes Aegypti Sequencing Announcement Jan. 30, 2006 Aedes Announcement July 26, 2006 Africa Malaria Day and Malaria Awareness Day, April 25, 2007, NIAID, NIH April 25, 2007 African Americans Inspiring Hope May 17, 2005 African Americans: Answers about HIV Vaccine Research, NIAID, NIH Oct. 1, 2008 Age of Optimism Feb. 28, 2006 Age-Based Screening is Cost-Effective Method to Control Chlamydial Infection Feb. 17, 1998 Agenda, 40th Tuberculosis and Leprosy Research Conference, US-Japan Cooperative Medical Science Program, NIAID, NIH July 25, 2007 Agenda, Mycobacteria Symposium, NIAID, NIH Sept. 3, 2008 Agenda, NIAID Food Allergy Clinical Guideline Development Coordinating Committee Meeting, September 2, 2008 Oct. 28, 2008 Agenda, Pediatric Tuberculosis Meeting, NIAID, NIH June 3, 2008 Agenda, Polio Immunization: Moving Forward, September 19-20, 2007, NIH Aug. 1, 2007 Agenda, Vaccines for Viral Infections in Developing Countries Aug. 2, 2006 Agenda: 40th Tuberculosis and Leprosy Research Conference, US-Japan Cooperative Medical Science Program Aug. 6, 2007 Agenda: Prevention of Group A Streptococcal Diseases and Their Sequelae Aug. 16, 2007 Agricultural Workers at Increased Risk for Infection with Animal Flu Viruses Nov. 25, 2005 AIDS Care in Africa Meeting, Kampala, Uganda, April 18-20, 2001, Slide 18, Dr. Anthony S. Fauci, July 7, 2001 July 7, 2001 AIDS Clinical Trials Group: Affiliated Clinical Trials Units and Clinical Research Sites July 24, 2007 AIDS Deaths in the United Stated: January 1985-June 1997, Slide 4, Dr. Anthony S. Fauci, September 16, 1998 Jan. 14, 1999 AIDS Deaths in the United States, 1/86-9/98, Slide 4, Dr. Anthony S. Fauci, July 9, 1999 July 16, 1999 AIDS Deaths in the United States, 1985-2000, Slide 20, Dr. Anthony S. Fauci, July 7, 2001 July 7, 2001 AIDS Deaths in the United States, January 1986 - June 1998, Slide 2, Dr. Anthony S. Fauci, 1999 March 5, 1999 AIDS Deaths in the United States: January 1985-June 1997, Poster 2 Jan. 18, 2005 AIDS Deaths in the United States: January 1985-June 1997, Slide 1, Dr. Anthony S. Fauci, March 18, 1998 Jan. 15, 1999 AIDS Drugs Have Saved 3 Million Years of Life in the United States June 2, 2006 AIDS Research Advisory Committee, NIAID, NIH Jan. 5, 2009 AIDS Research and Prevention, Slide 8, Dr. Anthony S. Fauci, September 16, 1998 Jan. 14, 1999 AIDS Research, Slide 10, Dr. Anthony S. Fauci, July 9, 1999 July 16, 1999 AIDS Vaccine 2007 Report Jan. 8, 2008 AIDS Vaccine 2008 Report Jan. 6, 2009 AIDS Vaccine Research (AVR) Workshop Agenda, Sept 16-17, 2008 Oct. 28, 2008 AIDS Vaccine Research Highlights July 8, 1996 AIDS Vaccine Research Subcommittee (AVRS), Dec 2007, HIV/AIDS, Vaccines, DAIDS, NIAID, NIH June 23, 2008 AIDS Vaccine Research Subcommittee (AVRS), May 2008, HIV/AIDS, Vaccines, DAIDS, NIAID, NIH July 17, 2008 AIDS Vaccine Research Subcommittee (AVRS), May 2009, HIV/AIDS, Vaccines, DAIDS, NIAID, NIH May 1, 2009 AIDS Vaccine Research Subcommittee (AVRS), September 2008, HIV/AIDS, Vaccines, DAIDS, NIAID, NIH Feb. 17, 2009 AIDS Vaccine Research Working Group (AVRWG) April 29, 2009 AIDS Vaccine Research Working Group (AVRWG) Committee Members Dec. 14, 2007 AIDS Vaccine Research Working Group Archived Meeting Summaries Oct. 18, 2007 AIDS Virus Reformatted to Shuttle Repair Genes to Diseased Brains April 11, 1996 Airborne Allergies: Something in the Air Feb. 12, 2008 Alan Sher, Immunobiology Section, Laboratory of Parasitic Diseases, NIAID, NIH Feb. 4, 2008 Alasdair M. Gilfillan, Ph.D., Mast Cell Biology Section, Laboratory of Allergic Diseases, NIAID, NIH July 8, 2008 Albert Z. Kapikian, M.D., Epidemiology Section, Laboratory of Infectious Diseases, NIAID, NIH May 22, 2006 Alfonso Gozalo, D.V.M., M.S., Veterinary Care, Comparative Medicine Branch, NIAID, NIH June 27, 2006 Alison McBride Ph.D., DNA Tumor Virus Section, Laboratory of Viral Diseases, NIAID, NIH Sept. 23, 2008 All About the VRC, VRC, NIAID, NIH Nov. 21, 2008 Allergic Diseases April 24, 2008 Allergic Diseases Clinical Studies Oct. 25, 2006 Allergic Diseases Introduction and Research Goals Oct. 24, 2006 Allergic Diseases Research Activities Feb. 19, 2008 Allergic Diseases Resources for Researchers Feb. 19, 2008 Allergy / Immunology Fellowship Application Process, NIAID, NIH Dec. 26, 2007 Allergy and Asthma April 28, 2009 Allergy and Immunology Training Program in the Division of Intramural Research (DIR), NIAID, NIH Nov. 13, 2006 Allergy News Releases, NIAID, NIH March 30, 2009 Allergy, Immunology, and Transplantation Research Committee, About NIAID, NIAID, NIH March 9, 2005 ALPS and the Immune System, Autoimmune Lymphoproliferative Syndrome (ALPS) Oct. 7, 2008 ALPS and Your Family, Autoimmune Lymphoproliferative Syndrome (ALPS) Oct. 7, 2008 Alteration in Cell Death Pathway Sheds Light on Autoimmune Disease July 8, 1999 Amendment #1 (Questions and Answers) to RFP NIH-NIAID-DMID-BAA-03-38, “Biodefense Proteomics Research Programs: Identifying Targets for Therapeutic Interventions Using Proteomic Technology” Oct. 1, 2008 Amendment #1 (Questions and Answers) to RFP-NIH-NIAID-DMID-03-34, "Biodefense and Emerging Infections Research Resources Program" Oct. 1, 2008 Amendment #1 to RFP NIH-NIAID-DMID-03-54, “Construction Quality Management (CQM) Support Services” Oct. 1, 2008 Amendment #1 to RFP-NIH-NIAID-DAIT-04-38 Oct. 1, 2008 Amendment #1 to RFP-NIH-NIAID-DMID 04-34, "Bioinformatics Resource Centers for Biodefense and Emerging/Re-emerging Infectious Diseases" Oct. 1, 2008 Amendment #1 to RFP-NIH-NIAID-DMID-03-29, "Production and Testing of Anthrax Recombinant Protective Antigen (rPA) Vaccine” Oct. 1, 2008 Amendment #1 to RFP-NIH-NIAID-DMID-03-45, "Administrative Resource for Biodefense Proteomic Centers" Oct. 1, 2008 Amendment #1, RFP NIH-NIAID-DMID-04-40, In Vitro and Animal Models for Emerging Diseases and BioDefense Oct. 1, 2008 Amendment #2 (Questions and Answers) to RFP-NIH-NIAID-DMID 04-34, "Bioinformatics Resource Centers for Biodefense and Emerging/Re-emerging Infectious Diseases" Oct. 1, 2008 Amendment #2 to RFP NIH-NIAID-DMID-03-45, “Administrative Resource for Biodenfense Proteomic Centers” Oct. 1, 2008 Amendment #2 to RFP NIH-NIAID-DMID-BAA-03-38, “Biodefense Proteomics Research Programs: Identifying Targets for Therapeutic Interventions Using Proteomic Technology” Oct. 1, 2008 Amendment #2 to RFP-NIH-NIAID-DMID-03-29, "Production and Testing of Anthrax Recombinant Protective Antigen (rPA) Vaccine” Oct. 1, 2008 Amendment #2 to RFP-NIH-NIAID-DMID-03-34, "Biodefense and Emerging Infections Research Resources Program" Oct. 1, 2008 Amendment #3 to RFP NIH-NIAID-DMID-BAA-03-38, “Biodefense Proteomics Research Programs: Identifying Targets for Therapeutic Interventions Using Proteomic Technology” Oct. 1, 2008 Amendment #3 to RFP-NIH-NIAID-DMID 04-34 Oct. 1, 2008 Amendment #3 to RFP-NIH-NIAID-DMID-03-29 Oct. 1, 2008 Amendment #4 to RFP NIH-NIAID-DMID-BAA-03-38 Oct. 1, 2008 Amendment #4, to RFP NIH-NIAID-DMID-03-45, “Administrative Resource for Biodenfense Proteomic Centers” Oct. 1, 2008 Amendment #5 to RFP NIH-NIAID-DMID-BAA-03-38 Oct. 1, 2008 Amendment of NIAID Solicitation RFP NIH-NIAID-DMID-03-39, "In vitro and Animal Models for Emerging Diseases and Biodefense" Oct. 1, 2008 Amino Acid Analysis and Conjugation Efficiency Assays, Technology, Peptide Synthesis, Research Technologies Branch, NIAID, NIH Jan. 21, 2009 An Ecologic Study of Prostate-specific Antigen Screening and Prostate Cancer Mortality in Nine Geographic Areas of the United States July 20, 2007 An HIV Vaccine — Evolving Concepts, NEJM, May 16, 2007 April 11, 2008 An HIV/AIDS Research Agenda in Developing Countries must be:, Slide 3, Dr. Esparza, July 7, 2001 July 6, 2001 An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-interferon Alfa 2b Every Two Weeks with Ribavirin Among HIV/HCV Coinfected Individuals Jan. 21, 2009 Analyses, Technology, Mass Spectrometry, Research Technologies Branch, NIAID, NIH March 21, 2007 Animal Models for Experimental Therapeutics and Vaccines Application Process, Services, DMID, NIAID, NIH July 7, 2008 Animal Models for Experimental Therapeutics and Vaccines Assurances, Services, DMID, NIAID, NIH July 7, 2008 Animal Models for Experimental Therapeutics and Vaccines Eligibility, Services, DMID, NIAID, NIH July 7, 2008 Animal Models for Hepatitis B and C Application, Services, DMID, NIAID July 3, 2008 Animal Models for Hepatitis B and C Assurances, Services, DMID, NIAID July 2, 2008 Animal Models for Hepatitis B and C Eligibility, Services, DMID, NIAID July 2, 2008 Animal Models for Hepatitis B and C Review, Services, DMID, NIAID July 3, 2008 Animal Models for Hepatitis B and C, Services, DMID, NIAID July 14, 2008 Animal Models for the Evaluation of Experimental Therapeutics and Vaccines Review Process, Services, DMID, NIAID, NIH July 7, 2008 Animal Models for the Evaluation of Experimental Therapeutics and Vaccines, Services, DMID, NIAID, NIH July 14, 2008 Animal Models, HIV/AIDS Vaccine Research June 21, 2006 Animal Studies July 17, 2008 Announcement of Availability of Overlapping Peptides for Influenza Proteome, January 27, 2006, Public Health Service, DHHS Oct. 1, 2008 Annual Commemorative Days, NIAID, NIH April 24, 2009 Anthony Fauci '58, Regis Alumni News Winter July 27, 2007 Anthony S. Fauci Awarded 2001 Frank Annunzio Award Oct. 4, 2001 Anthony S. Fauci Awarded Lasker Award for Public Service Sept. 14, 2007 Anthony S. Fauci Awarded the Highest Honor of the Association of American Physicians, NIAID, NIH April 13, 2007 Anthony S. Fauci to Present New Data on HIV Escape Mechanisms and HIV Suppressor Molecules Jan. 28, 1996 Anthony S. Fauci, M.D., Immunopathogenesis Section, Laboratory of Immunoregulation, NIAID, NIH May 12, 2008 Anthony S. Fauci, M.D., Lab Photo, 2007, NIAID, NIH April 13, 2007 Anthrax Feb. 19, 2009 Anthrax Cause Sept. 4, 2007 Anthrax Genome Decoded April 30, 2003 Anthrax Overview Feb. 19, 2009 Anthrax Prevention Feb. 19, 2009 Anthrax Related Links Feb. 19, 2009 Anthrax Research Feb. 19, 2009 Anthrax Treatment Feb. 19, 2009 Antibodies Gone Awry, Multiple Sclerosis Dec. 15, 2006 Antifungal Drug Helps Kids with Immune Disorder Avoid Hospitalization June 11, 2003 Antigen Development Unit, Malaria Vaccine Development Branch, NIAID, NIH Dec. 3, 2008 Antigenic Drift vs. Antigenic Shift, How the Flu Virus Changes,Flu (Influenza), NIAID, NIH Dec. 4, 2006 Antigenic Shift Illustration, How the Flu Virus Changes,Flu (Influenza), NIAID, NIH May 1, 2009 Anti-Herpes Drug Does Not Reduce Risk of HIV Infection in People with Genital Herpes Virus, Study Finds Feb. 6, 2008 Anti-HIV Gel Shows Promise in Large-scale Study in Women Feb. 9, 2009 Anti-HIV Treatment Improves Immune System and Fights Sight-Threatening Eye Infection Nov. 2, 1999 Antimicrobial (Drug) Resistance March 17, 2009 Antimicrobial (Drug) Resistance Research in NIAID Labs March 21, 2008 Antimicrobial (Drug) Resistance: A Growing Health Issue March 4, 2008 Antimicrobial Resistance - Selected Scientific Areas of Research Dec. 23, 2004 Antimicrobial Resistance News Releases, NIAID, NIH March 17, 2009 Antimicrobial Resistance: The NIH Response to a Growing Problem, Table of Contents, Dr. Anthony S. Fauci Feb. 23, 1999 Antimicrobial Resistance: The NIH Response to a Growing Problem. Statement of Anthony S. Fauci, MD, Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, February 25, 1999 Sept. 13, 1999 Antiretroviral Therapy (ART) to Reduce the Transmission of HIV April 21, 2008 Appendices - NIAID Profile FY 2003 Dec. 23, 2004 Appendices, NIAID Profile Fiscal Year 2004 Oct. 28, 2008 Appendices, NIAID Profile Fiscal Year 2005 Oct. 28, 2008 Appendix A: Aerosol System Flow Oct. 9, 2007 Appendix A: Aerosol System Flow April 27, 2009 Appendix A: Strategic Plan for Biodefense Research Sept. 7, 2007 Appendix B: Covered Sort Chamber Oct. 9, 2007 Appendix C: AeroTech Device Oct. 9, 2007 Appendix D: Position of the AeroTech Device Oct. 9, 2007 Appendix E: Glo-Germ Oct. 9, 2007 Appendix F: Collected Particles Oct. 9, 2007 Appendix G: Aerosol Cont. Report Oct. 9, 2007 Appendix H: Flow Lab Warning Oct. 9, 2007 Appendix I: Bio-Safety Suite Oct. 9, 2007 Appendix J: References Oct. 9, 2007 Application Information, Infectious Diseases Training Program, NIAID, NIH Feb. 24, 2009 Application Information, Working at NIAID, NIH March 30, 2001 Application Process, Clinical Laboratory Diagnostics for Invasive Aspergillosis, NIAID, NIH Nov. 12, 2008 Application Process, Clinical Proteomics, NIAID, NIH April 7, 2009 Application Process, Proteomics Research Centers, DMID, NIAID, NIH July 10, 2008 Application Process, Services for Preclinical Development of Therapeutic Agents, DMID, NIAID, NIH June 20, 2008 Application Process, Summer Internship Program in Biomedical Research, OTSEP, NIAID, NIH July 13, 2006 Approach to the Development of an HIV Vaccine, Poster 24 Jan. 18, 1999 Approaches to HIV Prevention, Poster 6 Jan. 18, 1999 Approaches to HIV Prevention, Slide 27, Dr. Anthony S. Fauci, July 7, 2001 July 7, 2001 Approaches to HIV Prevention, Slide 6, Dr. Anthony S. Fauci, September 16, 1998 Jan. 14, 1999 Approaches to HIV Prevention, Slide 7, Dr. Anthony S. Fauci, July 9, 1999 July 16, 1999 Approaches to Potency Assays of Pre-and Prepro-Biologic Vaccines: The Role of RT-PCR and Genetic Stability in Characterizing Potency of Plasmnid DNA-based Vaccines April 11, 2008 Approval Process, Clinical Laboratory Diagnostics for Invasive Aspergillosis, NIAID, NIH Sept. 29, 2008 Approval Process, Proteomics Research Centers, DMID, NIAID, NIH July 14, 2008 Approved Anit-HIV Drugs, Slide 5, Dr. Anthony S. Fauci, September 16, 1998 Jan. 14, 1999 Approved Anti-HIV Drugs, Slide 19, Dr. Anthony S. Fauci, July 7, 2001 July 7, 2001 Approved Anti-HIV Drugs, Slide 5, Dr. Anthony S. Fauci, July 9, 1999 July 16, 1999 Apr. 12, 2005 Pandemic Flu Posters Nov. 20, 2008 Apr. 12, 2005 Pandemic Flu Testimony Nov. 20, 2008 April 18, 2007 Biolshield Hearing Poster Nov. 21, 2008 April 18, 2007 Bioshield Congressional Testimony Nov. 21, 2008 Architectural Rendering, Building 33, NIAID, NIH May 1, 2006 Archive of Conferences and Meetings SummariesDivision of Allergy, Immunology, and Transplantation (DAIT), NIAID, NIH Aug. 9, 2005 Archive of NIAID in the News June 17, 2005 Archive of VRC Clinical Studies March 5, 2009 Archived Determination IND April 27, 2009 Archived Reports and Articles March 16, 2009 Archived Research Features, Flu (Influenza), NIAID, NIH Oct. 15, 2008 Arnold S. Kirshenbaum, M.D., Mast Cell Biology Section, Laboratory of Allergic Diseases, NIAID, NIH March 22, 2005 Article in Press, K.-L. Nguyen et al., Virology 2004 Aug. 1, 2007 Ascariasis Feb. 19, 2009 Ascariasis Cause Sept. 13, 2007 Ascariasis Diagnosis Feb. 19, 2009 Ascariasis Related Links Feb. 19, 2009 Ascariasis Research Sept. 13, 2007 Ascariasis Symptoms Sept. 13, 2007 Ascariasis Transmission Sept. 13, 2007 Ascariasis Treatment Sept. 13, 2007 Asexual Blood-Stage Vaccines, Malaria Vaccine Development Branch, NIAID, NIH Feb. 4, 2009 Ashish Jain, M.D., Clinical Immunology Unit, Laboratory of Host Defenses, NIAID, NIH March 12, 2008 Assay Requirements April 11, 2008 Assaying Potency of Novel Vaccines April 10, 2008 Assays For An AAV Vectored HIV Vaccine April 11, 2008 Assays for Bovine Viruses April 11, 2008 Association of American Physicians Presidential Address: The AIDS Model: Scientific and Policy Lessons for the 21st Century, Anthony S. Fauci July 19, 2007 Assurances, Clinical Laboratory Diagnostics for Invasive Aspergillosis, NIAID, NIH Sept. 29, 2008 Assurances, Clinical Proteomics, NIAID, NIH Sept. 4, 2008 Assurances, Preclinical Development of Therapeutic Agents, DMID, NIAID, NIH July 15, 2008 Asthma May 5, 2009 Asthma and Allergic Diseases, Selected Scientific Areas of Research Dec. 23, 2004 Asthma Facts Feb. 19, 2009 Asthma Networks, Partners, and Consortia Feb. 19, 2009 Asthma News Releases May 5, 2009 Asthma Research April 30, 2008 Asthma Research Activities and Resources April 29, 2008 Asthma Research Focus, NIAID, NIH Feb. 12, 2009 Asthma Research in NIAID Labs April 29, 2008 Asthma Researchers Present New Results, New Perspectives on the Disease Feb. 25, 2002 Asturias EJ, et al. J Infect Dis 2007;196 Dec. 2, 2008 Attachment II: Safety Monitoring Committee (SMC) Guidelines, DMID, NIAID, NIH April 27, 2009 Attachment III: Independent Safety Monitor (ISM) Guidelines, NIAID, NIH April 27, 2009 Aug. 11, 2004 - Work on the Building Interior May 2, 2006 Augmented Designs to Assess Immune Response in Vaccine Trials Aug. 6, 2007 Autoimmune Disease New Releases March 30, 2009 Autoimmune Diseases March 28, 2006 Autoimmune Diseases - Selected Scientific Areas of Research Dec. 23, 2004 Autoimmune Diseases Clinical Studies March 28, 2006 Autoimmune Diseases Related Publications and Links April 24, 2008 Autoimmune Diseases Research Activities Aug. 3, 2006 Autoimmune Diseases Research Plan, NIAID, NIH Sept. 14, 2007 Autoimmune Diseases Resources for Researchers March 28, 2006 Autoimmune Lymphoproliferative Syndrome (ALPS) March 18, 2009 AVRS May 2007 Summary Oct. 19, 2007 AVRWG Advice on Adenovirus Vectors, Jan 07, DAIDS, NIAID, NIH Aug. 6, 2007 AVRWG Workshop Summary, January 07, DAIDS, NIAID, NIH Aug. 6, 2007 Award Will Boost HIV/AIDS Research in China June 28, 2002 Awardees, Medical Countermeasures Against Radiological and Nuclear Threats, NIAID, NIH Oct. 8, 2008 Awards, Bioinformatics Resource Centers, NIAID, NIH Sept. 19, 2008 Awards, Centers of Excellence for Influenza Research and Surveillance, NIAID, NIH July 24, 2008 Awards, In Vitro and Animal Modules, Biodefense, NIAID, NIH March 10, 2008 Awards, Proteomics Research Centers, DMID, NIAID, NIH April 15, 2008 AZT and AIDS March 30, 2009

Home | Help | Site Index | Accessibility | Privacy Policy | Disclaimer | Links & Policies | FOIA | Contact Us National Institute of Allergy and Infectious Diseases (NIAID) National Institutes of Health (NIH) Department of Health and Human Services (HHS)